Αποτελέσματα Αναζήτησης
Find TiO2 nanoparticles and related products for scientific research at MilliporeSigma.
23 Οκτ 2024 · Abstract. This chapter showcases the potential of cell-derived extracellular nanovesicles (EVs) as an alternative platform for the development of nanoparticle-based vaccines. Exosomes are one such tiny cell secretory vesicles, responsible for multiple biological functions including intercellular communication and host pathogen interactions.
11 Αυγ 2021 · Nature Nanotechnology - Almost all currently used vaccines against COVID-19 consist of either non-viral or viral nanoparticles. Here we attempt to understand the reasons behind the success of...
27 Νοε 2020 · Two nanoparticle-based vaccines close to obtaining approval by the US Food and Drug Administration could represent a giant step in the fight against the COVID-19 pandemic. On 18 November...
2 Σεπ 2021 · The SARS-CoV-2 pandemic has heralded a coming-of-age for vaccine nanotechnology. Decades of groundwork optimizing new vaccine platforms allowed clinical trials with nanoparticle vaccine candidates to begin within 2 months of the SARS-CoV-2 genome sequence being made publicly available.
16 Ιουν 2022 · Several vaccines against COVID-19 use nanoparticles to protect the antigen cargo (either proteins or nucleic acids), increase the immunogenicity and ultimately the efficacy.
19 Αυγ 2022 · All of the current COVID-19 vaccines in the U.S., and the nanoparticle vaccines, use the spike gene from the original Wuhan strain of SARS-CoV-2, the virus that causes COVID-19. The difference is in how the spike proteins show up.
